NEWS + PRESS

Nitinol Devices & Components (“NDC”) is pleased to announce that Mark Lemma has joined the company as Chief Financial Officer. Mark comes to NDC with more than 25 years of financial, operational and administrative leadership across a variety of industries and geographies. Most recently, Mark served as Chief Financial Officer of Speculative Product Design, LLC ...continue reading

Nitinol Devices & Components (“NDC”) is pleased to announce that David Johnston has joined our team as Vice President, Costa Rica Operations.  David comes to NDC with more than 20 years of medical product operations, supply chain and manufacturing experience including work at companies that include VertiSync LLC, Accellent, and Arthur Anderson Business Consulting. Most ...continue reading

Today Nitinol Devices & Components (“NDC”) launched a new corporate brand strategy that elevates the company’s corporate identity and underscores its unique abilities to support medical device manufacturers from concept generation to commercial scale production. The new strategy emphasizes NDC’s specific capabilities and expertise in working with Nitinol-based devices for endovascular, peripheral vascular, cardiovascular, neurovascular ...continue reading

Nitinol Devices & Components (NDC) today announced the appointment of Dean Schauer as its President and CEO, effective September 1, 2013. “We are delighted to welcome someone as singularly qualified as Dean to take NDC to the next stage of its development,” said Tom Duerig, current President and CEO. “Dean is an experienced senior executive ...continue reading

Continuing a tradition of technological excellence and innovation, NDC recently introduced an extra-low interstitial (ELI) version of its proven SE-508 alloy which has served as the medical device industry’s leading implantable Nitinol for nearly two decades.  This revolution in material purity stems from ten years of research with their primary melting partner, ATI Wah Chang, ...continue reading